On Oct. 4, 2023, ASTHO, CDC, the Center for Law and Social Policy, and Mental Health America released a framework for public health leaders with effective strategies to improve mental health and ...
On Feb. 26, 2024, ASTHO's CMO issued a statement in response to several measles outbreaks currently occurring in the United States.
On Jan. 23, 2023, ASTHO announced it has been awarded funding from the FDA to advance retail food safety initiatives and reduce food-borne illness.
ASTHO Commends the Surgeon General Advisory about Marijuana Use on the Developing Brain ARLINGTON, VA—Michael Fraser, Chief Executive Officer of the Association of State and Territorial Health ...
ASTHO Urges Swift Approval of Bipartisan Budget Deal ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) applauds the bipartisan budget deal to increase funding for ...
ASTHO Statement on House FY20 Appropriations Bill ARLINGTON, VA—Michael Fraser, chief executive officer of ASTHO, issued the following statement applauding the House FY20 Labor, Health and Human ...
Walgreens and Rite Aid Make Good Public Health Move on Raising Age to Purchase Tobacco, but More Is Needed ARLINGTON, VA—Nicole Alexander-Scott, MD, MPH, director of the Rhode Island Department of ...
State and Local Health Officials at the Capitol to Urge Congress to Prioritize Funding for Public Health ARLINGTON, VA—Over 80 state, local, and territorial health officials from across the country ...
Current Measles Outbreaks Should Alarm Every American and Highlight the Critical Importance of Vaccination Programs ARLINGTON, VA—John Wiesman, DrPH, MPH, secretary of health at the Washington State ...
On Aug. 11, 2022, ASTHO's Chief Medical Officer issued a statement of support for CDC's new COVID-19 guidelines.
On July 15, 2021, ASTHO CEO, Michael Fraser, PhD, issued a statement support for U.S. Surgeon General Vivek Murthy’s new advisory "Confronting Misinformation: The U.S. Surgeon General’s Advisory ...
On July 13, 2021, ASTHO issued a statement of support for President Joe Biden’s nomination of Rahul Gupta, MD, MPH, MBA, FACP, to serve as the Director of the Office of National Drug Control Policy.
ASTHO issued a statement of concern for public health and healthcare workers on June 25, 2021, following the publication of a CDC MMWR Early Release, that details the devastating effects of the ...
On May 13, 2021, ASTHO CEO Michael Fraser issued a strong statement of support for the Biden administration's American Rescue Plan Act of 2021, which includes a large investment in public heath.
On April 29, 2021, ASTHO and its members announced support for FDA actions in advancing two tobacco product standards rulemaking processes to remove menthol as a characterizing flavor in cigarettes ...
On Oct. 22, 2020, in preparation for National Vote Early Day, ASTHO joined voter education groups and local public health agencies to remind voters of steps they can take to ensure they stay healthy ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...
ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s ...
On March 23, 2023, ASTHO President Anne Zink testified before the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
Journal of Public Health Management and Practice Releases Studies Analyzing Largest Ever Public Health Workforce Survey